Vitamin B6 in the treatment of akathisia
Phase 2
- Conditions
- medication-induced acute akathisia.Other extrapyramidal and movement disorders
- Registration Number
- IRCT201111042935N6
- Lead Sponsor
- Vice chancellor for research, Kurdistan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
being hospitalized ;receiving neuroleptic
medication; Presence of akathisia based on DSM-IV criteria; Baseline
Barnes Akathisia Scale (BAS) score of at least 2
Exclusion criteria: any hepatic or renal
disease; change in the dose of anticholinergic drugs within 5 days
before the trial; receiving any beta-blocker medication during the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of akathisia. Timepoint: baseline and every day up to 5 days. Method of measurement: Barnes Akathisia Scale (BAS).
- Secondary Outcome Measures
Name Time Method